Apelin levels in pregnant women with and without gestational diabetes mellitus : a collaborative systematic review and meta-analysis
Aims: This systematic review and meta-analysis investigated maternal apelin levels in pregnant women with and without GDM. Secondary outcomes were glucose- and lipid-related results.Methods: Databases including PubMed, Embase, Cochrane Library, LILACS, CNKI, and Wang Fang were searched. The methodological quality of included studies was evaluated with the Newcastle-Ottawa Scale. Mean differences (MDs) or standardized MDs (SMDs) with their 95% confidence intervals (CIs) were evaluated. Random effect model analyses were carried out and heterogeneity with the I2 and Tau2 statistics.Results: Fourteen observational studies (sample size: 1033 women with GDM and 1053 for control women) with a low or moderate risk of bias were included in the analysis. During the second half of pregnancy, maternal apelin estimate was significantly higher in women with GDM (SMD = 0.64; 95% CI: 0.03 to 1.25), as well as insulin (SMD = 1.41% CI: 0.84 to 1.99), glucose (SMD = 1.56; 95% CI 1.20 to 1.91), glycated hemoglobin (SMD = 1.11, 95% CI: 0.69 to 1.54), HOMA-IR (MD = 2.25; 95%CI: 1.51 to 2.98), BMI (MD = 0.80 kg/m2, 95%CI: 0.52 to 1.08), total cholesterol (SMD = 0.42, 0.12 to 0.73), LDL-cholesterol (SMD = 0.63, 95%CI: 0.23 to 1.02), and triglycerides (SMD = 0.40, 95%CI: 0.19 to 0.61) as compared to control women. There was heterogeneity between studies as evidence by high I2 values. Meta-regression analysis indicated statistically significant regression coefficients for age of women, glucose and total cholesterol.Conclusions: GDM was associated with increased circulating apelin, insulin, glucose, glycated hemoglobin, total cholesterol, LDL-cholesterol levels, and HOMA-IR index.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology - 38(2022), 10 vom: 23. Okt., Seite 803-812 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pérez-López, Faustino R [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 11.11.2022 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09513590.2022.2114450 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345214218 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345214218 | ||
003 | DE-627 | ||
005 | 20231226024546.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09513590.2022.2114450 |2 doi | |
028 | 5 | 2 | |a pubmed24n1150.xml |
035 | |a (DE-627)NLM345214218 | ||
035 | |a (NLM)36002980 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pérez-López, Faustino R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Apelin levels in pregnant women with and without gestational diabetes mellitus |b a collaborative systematic review and meta-analysis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.11.2022 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Aims: This systematic review and meta-analysis investigated maternal apelin levels in pregnant women with and without GDM. Secondary outcomes were glucose- and lipid-related results.Methods: Databases including PubMed, Embase, Cochrane Library, LILACS, CNKI, and Wang Fang were searched. The methodological quality of included studies was evaluated with the Newcastle-Ottawa Scale. Mean differences (MDs) or standardized MDs (SMDs) with their 95% confidence intervals (CIs) were evaluated. Random effect model analyses were carried out and heterogeneity with the I2 and Tau2 statistics.Results: Fourteen observational studies (sample size: 1033 women with GDM and 1053 for control women) with a low or moderate risk of bias were included in the analysis. During the second half of pregnancy, maternal apelin estimate was significantly higher in women with GDM (SMD = 0.64; 95% CI: 0.03 to 1.25), as well as insulin (SMD = 1.41% CI: 0.84 to 1.99), glucose (SMD = 1.56; 95% CI 1.20 to 1.91), glycated hemoglobin (SMD = 1.11, 95% CI: 0.69 to 1.54), HOMA-IR (MD = 2.25; 95%CI: 1.51 to 2.98), BMI (MD = 0.80 kg/m2, 95%CI: 0.52 to 1.08), total cholesterol (SMD = 0.42, 0.12 to 0.73), LDL-cholesterol (SMD = 0.63, 95%CI: 0.23 to 1.02), and triglycerides (SMD = 0.40, 95%CI: 0.19 to 0.61) as compared to control women. There was heterogeneity between studies as evidence by high I2 values. Meta-regression analysis indicated statistically significant regression coefficients for age of women, glucose and total cholesterol.Conclusions: GDM was associated with increased circulating apelin, insulin, glucose, glycated hemoglobin, total cholesterol, LDL-cholesterol levels, and HOMA-IR index | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Apelin | |
650 | 4 | |a HOMA-IR | |
650 | 4 | |a body mass index | |
650 | 4 | |a gestational diabetes mellitus | |
650 | 4 | |a glucose | |
650 | 4 | |a insulin | |
650 | 4 | |a lipids | |
650 | 4 | |a meta-analysis | |
650 | 4 | |a 体重指数 | |
650 | 4 | |a 妊娠期糖尿病 | |
650 | 4 | |a 胰岛素 | |
650 | 4 | |a 脂类 | |
650 | 4 | |a 荟萃分析 | |
650 | 4 | |a 血糖 | |
650 | 7 | |a Apelin |2 NLM | |
650 | 7 | |a Glycated Hemoglobin A |2 NLM | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
650 | 7 | |a Cholesterol, LDL |2 NLM | |
700 | 1 | |a Wu, Jiang-Nan |e verfasserin |4 aut | |
700 | 1 | |a Yao, Li |e verfasserin |4 aut | |
700 | 1 | |a López-Baena, María T |e verfasserin |4 aut | |
700 | 1 | |a Pérez-Roncero, Gonzalo R |e verfasserin |4 aut | |
700 | 1 | |a Varikasuvu, Seshadri Reddy |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology |d 1996 |g 38(2022), 10 vom: 23. Okt., Seite 803-812 |w (DE-627)NLM013051202 |x 1473-0766 |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2022 |g number:10 |g day:23 |g month:10 |g pages:803-812 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09513590.2022.2114450 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 38 |j 2022 |e 10 |b 23 |c 10 |h 803-812 |